Ketamine was originally approved by the FDA as an anesthetic, but is increasingly being used to treat mood disorders such as treatment-resistant depression, anxiety disorders, and PTSD.
Researchers found that there has been little attention paid to intervention to enhance treatment adherence in nonpsychotic major depression, so they outlined steps for engagement, retention, and adherence for these patients.
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
A growing body of research suggests there may be associations between common viral infectious such as Epstein Barr and Toxoplasma gondii and schizophrenia.
The complexities of today’s high-tech methods of communication, data sharing, and data storage lay practices open to unforeseen and constantly changing threats, requiring vigilance and training of medical staff.